Yahoo Finance

GLUCOTRACK ANNOUNCES NEW FUNDING FOR DEVELOPMENT OF ITS CONTINUOUS BLOOD GLUCOSE MONITOR

Rutherford, NJ, July 31, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and ...
Yahoo Finance

GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION ...

Rutherford, NJ, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company"), a medical technology company focused on the design, development, and ...
Nasdaq

GlucoTrack to Present at TechBio Showcase 2025

Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener GlucoTrack ( (GCTK) ...
Nasdaq

Glucotrack, Inc. Successfully Repurchases Over 90% of Series A Warrants as Part of Capital Formation Strategy

Glucotrack repurchased over 90% of its Series A Warrants, strengthening its capital structure and demonstrating confidence in product development. Glucotrack, Inc. has announced the successful ...
Benzinga.com

Glucotrack Commences Transition From Concept To Reality With Breakthrough Clinical Trial

Glucotrack, Inc. GCTK reports it has achieved a significant milestone in its mission to transform diabetes management through three distinct advances: direct blood glucose measurement, hassle-free ...
manilatimes

Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development

RUTHERFORD, N.J., May 20, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people ...
Morningstar

Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas

The Glucotrack Continuous Blood Glucose Monitor is an Investigational Device and is limited by federal (or United States) law to investigational use. For more information about Glucotrack’s CBGM, ...
Yahoo Finance

Glucotrack Announces Repurchase of Series A Warrants

RUTHERFORD, N.J., July 08, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people ...
manilatimes

Glucotrack, Inc. Encourages Shareholders to Vote

RUTHERFORD, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack” or the "Company”), a medical technology company focused on the design, development, and ...
The Globe and Mail

Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements

Rutherford, NJ, June 12, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and ...
Investing

Glucotrack exchanges $600,000 note for 895,000 shares with investor

Under the agreement, Glucotrack and the investor exchanged the new $600,000 note for 895,000 shares of the company’s common stock. The exchange involved the surrender and cancellation of the note, and ...
Dhaka Tribune

GlucoTrack up 49% premarket after 240% rise last week - but coming down off highs

GlucoTrack (NASDAQ: GTCK) stock is already coming down off the highs of late last week. There was a vast leap - 240% - in GTCK at the end of the trading week, Thursday. This has carried on into ...